Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy

Intern Med. 2022 May 15;61(10):1603-1608. doi: 10.2169/internalmedicine.7701-21. Epub 2021 Nov 6.

Abstract

A 41-year-old woman was diagnosed with polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome based on polyneuropathy, hepatosplenomegaly, sclerotic bone lesions, IgA-λ M-protein, and an elevated level of serum vascular endothelial growth factor. One month after the initiation of lenalidomide-dexamethasone with prophylactic aspirin, she developed facial paralysis, dysarthria, and left hemiplegia. Multiple cerebral infarctions and internal carotid artery stenosis were detected. Five months after switching to pomalidomide-dexamethasone, she again developed cerebral infarction. Progressed stenotic lesions in the bilateral internal carotid artery terminal portions were detected, showing a moyamoya disease-like appearance. Quasi-moyamoya disease can be an important phenotype of systemic vasculopathies of POEMS syndrome.

Keywords: IMiDs; POEMS syndrome; cerebral infarction; quasi-moyamoya disease; vasculopathy.

Publication types

  • Case Reports

MeSH terms

  • Cerebrovascular Disorders*
  • Dexamethasone / therapeutic use
  • Female
  • Humans
  • Moyamoya Disease* / complications
  • Moyamoya Disease* / diagnostic imaging
  • POEMS Syndrome* / complications
  • POEMS Syndrome* / diagnosis
  • Phenotype
  • Vascular Endothelial Growth Factor A

Substances

  • Vascular Endothelial Growth Factor A
  • Dexamethasone

Supplementary concepts

  • Moyamoya disease 1